logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Małgorzata Nowicka

genentech, inc. , south san francisco 94080, ca ,
H指数:19
被引数:3,702

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SPEX: A modular end-to-end platform for high-plex tissue spatial omics analysis

SPEX：一个模块化的端到端平台，用于高通量组织空间组学分析

GigaScience
IF3.9
2025-08-290
OAAI
Xiao Li; Ximo Pechuan-Jorge; Tyler Risom; Conrad Foo; Alexander Prilipko; Artem Zubkov; Caleb Chan; Patrick Chang; Frank Peale; James Ziai; Sandra Rost; Derrek Hibar; Lisa McGinnis; Evgeniy Tabatsky; Xin Ye; Hector Corrada Bravo; Zhen Shi; Malgorzata Nowicka; Jon Scherdin; James Cowan; Jennifer Giltnane; Darya Orlova; Rajiv Jesudason
ALINA: Exploratory biomarker analyses in patients (pts) with resected ALK plus non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo)

ALINA：在接受了手术切除的ALK阳性非小细胞肺癌（NSCLC）患者中，接受辅助阿来替尼治疗与接受化疗的患者的探索性生物标志物分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-014
PRE
Solomon, B. J.; Wu, Y-L.; Dziadziuszko, R.; Barlesi, F.; Nishio, M.; Ahn, J. S.; Horinouchi, H.; Hochmair, M. J.; de Marinis, F.; Migliorino, M. R.; Kurochkin, A.; Harputluoglu, H.; Planchard, D.; Korphaisarn, K.; Han, J-Y.; Lohmann, T.; Gavaldon, A. Cardona; Archer, V. R.; Nowicka, M.; Noe, J.
Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancer

在1b期研究中，结合PARP和MEK抑制，有或没有anti-PD-L1，对BRCA野生型，铂敏感，复发性卵巢癌患者的主要结果和特征

CANCER
IF5.1
2024-01-301
OAAI
Mutch, David; Voulgari, Athina; Chen, Xian (Marissa); Bradley, William H.; Oaknin, Ana; Perez Fidalgo, Jose Alejandro; Montosa, Fernando Galvez; Herraez, Antonio Casado; Holloway, Robert W.; Powell, Matthew A.; Nowicka, Malgorzata; Schaefer, Gabriele; Merchant, Mark; Yan, Yibing
Circulating Cell-free DNA as a Prognostic Biomarker in Patients with Advanced ALK plus Non-small Cell Lung Cancer in the Global Phase III ALEX Trial

在全球III期ALEX试验中，循环无细胞DNA作为晚期ALK合并非小细胞肺癌患者的预后生物标志物

CLINICAL CANCER RESEARCH
IF10.2
2022-02-2326
OAAI
Dziadziuszko, Rafal; Peters, Solange; Mok, Tony; Camidge, D. Ross; Gadgeel, Shirish M.; Ou, Sai-Hong Ignatius; Konopa, Krzysztof; Noe, Johannes; Nowicka, Malgorzata; Bordogna, Walter; Morcos, Peter N.; Smoljanovic, Vlatka; Shaw, Alice T.
Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer

来自新辅助Ipatasertib加紫杉醇治疗三阴性乳腺癌的FAIRLANE试验的AKT信号和反应生物标志物的功能定位

CLINICAL CANCER RESEARCH
IF10.2
2021-12-1332
OAAI
Shi, Zhen; Wulfkuhle, Julia; Nowicka, Malgorzata; Gallagher, Rosa, I; Saura, Cristina; Nuciforo, Paolo G.; Calvo, Isabel; Andersen, Jay; Passos-Coelho, Jose Luis; Gil-Gil, Miguel J.; Bermejo, Begona; Pratt, Debra A.; Ciruelos, Eva M.; Villagrasa, Patricia; Wongchenko, Matthew J.; Petricoin, Emanuel F.; Oliveira, Mafalda; Isakoff, Steven J.
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma
BLOOD ADVANCES
IF7.1
2021-07-2911
OA
Strefford, Jonathan C.; Nowicka, Malgorzata; Hargreaves, Chantal E.; Burton, Cathy; Davies, Andrew; Ganderton, Rosalind; Hiddemann, Wolfgang; Iriyama, Chisako; Klapper, Wolfram; Latham, Kate, V; Martelli, Maurizio; Mir, Farheen; Parker, Helen; Potter, Kathleen N.; Rose-Zerilli, Matthew J. J.; Sehn, Laurie H.; Trneny, Marek; Vitolo, Umberto; Bolen, Christopher R.; Klein, Christian; Knapp, Andrea; Oestergaard, Mikkel Z.; Cragg, Mark S.
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment
BLOOD ADVANCES
IF7.1
2021-07-298
OA
Nowicka, Malgorzata; Hilton, Laura K.; Ashton-Key, Margaret; Hargreaves, Chantal E.; Lee, Chern; Foxall, Russell; Carter, Matthew J.; Beers, Stephen A.; Potter, Kathleen N.; Bolen, Christopher R.; Klein, Christian; Knapp, Andrea; Mir, Farheen; Rose-Zerilli, Matthew; Burton, Cathy; Klapper, Wolfram; Scott, David W.; Sehn, Laurie H.; Vitolo, Umberto; Martelli, Maurizio; Trneny, Marek; Rushton, Christopher K.; Slack, Graham W.; Farinha, Pedro; Strefford, Jonathan C.; Oestergaard, Mikkel Z.; Morin, Ryan D.; Cragg, Mark S.

研究方向

暂未获取到该数据
M
Mark D. Robinson
H 指数:82论文数:466被引数:9.2万
K
Katarzyna Obarska
H 指数:4论文数:12被引数:83
P
Przemysław Marcowski
H 指数:7论文数:28被引数:213
K
Karol Szymczak
H 指数:3论文数:8被引数:56
L
Lukas M. Weber
H 指数:26论文数:101被引数:5,573
M
Mateusz Gola
H 指数:37论文数:127被引数:4,769
K
Karol Lewczuk
H 指数:21论文数:74被引数:1,748
A
Alicja Anna Binkowska
H 指数:4论文数:16被引数:43
M
Maria Banaszak
H 指数:2论文数:9被引数:5
B
Bohdan Woronowicz
H 指数:5论文数:23被引数:242